Literature DB >> 10633337

Thyroid disease and its treatment: short- and long-term consequences.

J A Franklyn1.   

Abstract

Thyroid dysfunction is common, with up to 5% of the population affected by hyper- or hypothyroidism. Short-term effects of overt thyroid dysfunction are well recognised: for example, effects of hyperthyroidism on pulse rate or blood pressure and effects of hypothyroidism on lipids. There is now also increasing evidence for long-term morbidity and mortality associated with thyroid dysfunction. This includes an increased likelihood of cardiovascular and cerebrovascular mortality in subjects with previous thyrotoxicosis treated with radioiodine, and of osteoporotic fracture of the femur in those with previous thyrotoxicosis. Subclinical or mild thyroid dysfunction may also be associated with long-term effects, with evidence for increased risk of atrial fibrillation in those with subclinical hyperthyroidism. Treatment for thyroid disease may also cause long-term problems. The cancer risk associated with therapeutic radioiodine for hyperthyroidism has been investigated extensively. Our own studies reveal no increase in cancer diagnoses or deaths, apart from a small increase in thyroid cancer risk which may be associated with the underlying thyroid disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10633337

Source DB:  PubMed          Journal:  J R Coll Physicians Lond        ISSN: 0035-8819


  8 in total

1.  Long-term risks in hyperthyroid patients treated with radioiodine: is there anything new?

Authors:  Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09       Impact factor: 9.236

Review 2.  A review of the evidence for and against increased mortality in hypothyroidism.

Authors:  Marianne Thvilum; Frans Brandt; Thomas H Brix; Laszlo Hegedüs
Journal:  Nat Rev Endocrinol       Date:  2012-03-06       Impact factor: 43.330

3.  Duration of thyroid dysfunction correlates with all-cause mortality. the OPENTHYRO Register Cohort.

Authors:  Anne Sofie Laulund; Mads Nybo; Thomas Heiberg Brix; Bo Abrahamsen; Henrik Løvendahl Jørgensen; Laszlo Hegedüs
Journal:  PLoS One       Date:  2014-10-23       Impact factor: 3.240

4.  Efficacy of Low-dose (2 millicurie) versus Standard-dose (4 millicurie) Radioiodine Treatment for Cats with Mild-to-Moderate Hyperthyroidism.

Authors:  J M Lucy; M E Peterson; J F Randolph; P V Scrivani; M Rishniw; D L Davignon; M S Thompson; J M Scarlett
Journal:  J Vet Intern Med       Date:  2017-02-03       Impact factor: 3.333

Review 5.  Hyperthyroid cats and their kidneys: a literature review.

Authors:  L Yu; L Lacorcia; T Johnstone
Journal:  Aust Vet J       Date:  2022-06-16       Impact factor: 1.343

6.  In contrast to matrix metalloproteinases, serum adiponectin concentrations increase after radioiodine treatment of thyrotoxicosis.

Authors:  A Lewiński; A Brona; Kc Lewandowski; E Skowrońska-Jóźwiak; A Milewicz
Journal:  Thyroid Res       Date:  2012-10-29

7.  Effects of radioiodine administration on serum concentrations of matrix metalloproteinases, adiponectin and thrombospondin-1.

Authors:  Andrzej Lewinski; Anna Brona; Krzysztof C Lewandowski; Diana Jedrzejuk; Anna Bohdanowicz-Pawlak; Elżbieta Skowronska-Jozwiak; Małgorzata Bienkiewicz; Andrzej Milewicz
Journal:  Thyroid Res       Date:  2013-08-06

8.  Congenital thyroid hemiagenesis with thyroid nodules-Role of TI-RADS to prevent long term thyroid replacement therapy.

Authors:  Ashish Verma; S K Bhartiya; S P Basu; V K Shukla; Ram C Shukla
Journal:  Int J Surg Case Rep       Date:  2016-08-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.